125 related articles for article (PubMed ID: 23528258)
21. Evaluation of Potential Anti-Hepatitis A Virus 3C Protease Inhibitors Using Molecular Docking.
Sasaki-Tanaka R; Nagulapalli Venkata KC; Okamoto H; Moriyama M; Kanda T
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682728
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis A viral load in relation to severity of the infection.
Fujiwara K; Kojima H; Yasui S; Okitsu K; Yonemitsu Y; Omata M; Yokosuka O
J Med Virol; 2011 Feb; 83(2):201-7. PubMed ID: 21181913
[TBL] [Abstract][Full Text] [Related]
23. Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells.
Kanda T; Yokosuka O; Imazeki F; Fujiwara K; Nagao K; Saisho H
Biochem Biophys Res Commun; 2005 Jun; 331(2):621-9. PubMed ID: 15850805
[TBL] [Abstract][Full Text] [Related]
24. Recombination in hepatitis A virus: evidence for reproductive isolation of genotypes.
Belalov IS; Isaeva OV; Lukashev AN
J Gen Virol; 2011 Apr; 92(Pt 4):860-72. PubMed ID: 21216988
[TBL] [Abstract][Full Text] [Related]
25. Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virus.
Win NN; Kanda T; Ogawa M; Nakamoto S; Haga Y; Sasaki R; Nakamura M; Wu S; Matsumoto N; Matsuoka S; Kato N; Shirasawa H; Yokosuka O; Okamoto H; Moriyama M
Int J Med Sci; 2019; 16(10):1366-1370. PubMed ID: 31692913
[TBL] [Abstract][Full Text] [Related]
26. Additive Effects of Zinc Chloride on the Suppression of Hepatitis A Virus Replication by Interferon in Human Hepatoma Huh7 Cells.
Kanda T; Sasaki R; Masuzaki R; Takahashi H; Fujisawa M; Matsumoto N; Okamoto H; Moriyama M
In Vivo; 2020; 34(6):3301-3308. PubMed ID: 33144437
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility of Autographa californica multiple nucleopolyhedrovirus to inhibitors of DNA replication.
Thumbi DK; Arif BM; Krell PJ
J Virol Methods; 2007 Dec; 146(1-2):209-17. PubMed ID: 17706798
[TBL] [Abstract][Full Text] [Related]
28. Combating enterovirus replication: state-of-the-art on antiviral research.
Thibaut HJ; De Palma AM; Neyts J
Biochem Pharmacol; 2012 Jan; 83(2):185-92. PubMed ID: 21889497
[TBL] [Abstract][Full Text] [Related]
29. Novel flavonoid hybrids as potent antiviral agents against hepatitis A: Design, synthesis and biological evaluation.
Shi S; Zheng X; Suzuki R; Li Z; Shiota T; Wang J; Hirai-Yuki A; Liu Q; Muramatsu M; Song SJ
Eur J Med Chem; 2022 Aug; 238():114452. PubMed ID: 35597006
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity.
Gentzsch J; Hinkelmann B; Kaderali L; Irschik H; Jansen R; Sasse F; Frank R; Pietschmann T
Antiviral Res; 2011 Feb; 89(2):136-48. PubMed ID: 21167208
[TBL] [Abstract][Full Text] [Related]
31. Stable growth of wild-type hepatitis A virus in cell culture.
Konduru K; Kaplan GG
J Virol; 2006 Feb; 80(3):1352-60. PubMed ID: 16415012
[TBL] [Abstract][Full Text] [Related]
32. Occurrence of hepatitis A virus genotype III in Germany requires the adaptation of commercially available diagnostic test systems.
Heitmann A; Laue T; Schottstedt V; Dotzauer A; Pichl L
Transfusion; 2005 Jul; 45(7):1097-105. PubMed ID: 15987353
[TBL] [Abstract][Full Text] [Related]
33. Masitinib Inhibits Hepatitis A Virus Replication.
Sasaki-Tanaka R; Shibata T; Moriyama M; Kogure H; Hirai-Yuki A; Okamoto H; Kanda T
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298659
[TBL] [Abstract][Full Text] [Related]
34. Fisetin and rutin as 3C protease inhibitors of enterovirus A71.
Lin YJ; Chang YC; Hsiao NW; Hsieh JL; Wang CY; Kung SH; Tsai FJ; Lan YC; Lin CW
J Virol Methods; 2012 Jun; 182(1-2):93-8. PubMed ID: 22465253
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.
Deterding K; Tegtmeyer B; Cornberg M; Hadem J; Potthoff A; Böker KH; Tillmann HL; Manns MP; Wedemeyer H
J Hepatol; 2006 Dec; 45(6):770-8. PubMed ID: 17034895
[TBL] [Abstract][Full Text] [Related]
36. Suppression of La antigen exerts potential antiviral effects against hepatitis A virus.
Jiang X; Kanda T; Wu S; Nakamoto S; Saito K; Shirasawa H; Kiyohara T; Ishii K; Wakita T; Okamoto H; Yokosuka O
PLoS One; 2014; 9(7):e101993. PubMed ID: 24999657
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of AIDS virus replication by acemannan in vitro.
Kahlon JB; Kemp MC; Carpenter RH; McAnalley BH; McDaniel HR; Shannon WM
Mol Biother; 1991 Sep; 3(3):127-35. PubMed ID: 1768365
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of the replication of hepatitis B virus in vitro by emodin.
Shuangsuo D; Zhengguo Z; Yunru C; Xin Z; Baofeng W; Lichao Y; Yan'an C
Med Sci Monit; 2006 Sep; 12(9):BR302-6. PubMed ID: 16940925
[TBL] [Abstract][Full Text] [Related]
39. Application of an In-Cell Western assay for measurement of influenza A virus replication.
Wan Y; Zhou Z; Yang Y; Wang J; Hung T
J Virol Methods; 2010 Nov; 169(2):359-64. PubMed ID: 20709106
[TBL] [Abstract][Full Text] [Related]
40. Influence of twenty potentially antiviral substances on in vitro multiplication of hepatitis A virus.
Widell A; Hansson BG; Oberg B; Nordenfelt E
Antiviral Res; 1986 Mar; 6(2):103-12. PubMed ID: 3010855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
